Fortune Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Sell
2,542
-67
-3% -$14.4K 0.27% 83
2026
Q1
$567K Buy
+2,609
New +$579K 0.29% 81
2025
Q2
Sell
-1,044
Closed -$219K 96
2025
Q1
$219K Buy
+1,044
New +$203K 0.19% 91
2024
Q4
Sell
-1,039
Closed -$205K 89
2024
Q3
$205K Buy
+1,039
New +$194K 0.19% 87
2024
Q2
Sell
-2,785
Closed -$507K 123
2024
Q1
$507K Sell
2,785
-14
-0.5% -$2.41K 0.32% 86
2023
Q4
$434K Sell
2,799
-376
-12% -$54.8K 0.3% 82
2023
Q3
$473K Buy
3,175
+5
+0.2% +$734 0.36% 70
2023
Q2
$427K Buy
+3,170
New +$465K 0.32% 79

Other funds holding ABBV

Fortune Financial Advisors's ABBV Position: Q2 2026 in Review

Fortune Financial Advisors reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $14.4K and leaving 2,542 shares worth $640K. The position accounts for 0.27% of the portfolio, ranked #83.

Fortune Financial Advisors first reported a position in ABBV in Q2 2023 and has held it in 8 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fortune Financial Advisors held 2,542 shares of AbbVie worth $640K as of Q2 2026.
  • Fortune Financial Advisors sold 67 AbbVie shares in Q2 2026, an estimated $14.4K.
  • AbbVie made up 0.27% of Fortune Financial Advisors's portfolio in Q2 2026, its #83 holding.
  • Fortune Financial Advisors first reported a position in AbbVie in Q2 2023 and has held it in 8 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fortune Financial Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.